English TOP- Noile-Immune Biotech Inc.

News

2025/02/19: Publishment of a dialogue article about Koji Tamada, President and CEO of Noile-Immune Inc., in Nikkei Biotechnology and Business; A dialogue article between Keiichi Fukuda, CEO, Representative Director of the Board of Heartseed Inc. and Koji Tamada, Representative Director, President & CEO of Noile-Immune Biotech Inc., which took place at the Summit of Startups from Keio University School of Medicine, was published in Nikkei Biotechnology and Business (February 19, 2025).
Topic : https://bio.nikkeibp.co.jp/atcl/news/p1/25/02/13/12960/(This article is only written by Japanese, so sorry for your inconvenience)

2025/02/04: Notice of Option Agreement with the University of Tokyo for Polymer Compound for Nucleic Acid Delivery

2025/01/31: An interview article about Koji Tamada, Professor at Yamaguchi University and President and CEO of Noile-Immune, entitled "Cutting-Edge Medicine: Featured Keywords", was published in the March issue of "KATEIGAHO" (on sale January 31, 2025).(This article is only written by Japanese, so sorry for your inconvenience)

2025/01/17: Publishment of a newspaper article about the "<Osaka> Bio IR Day" hosted by the Nihon Securities Journal Inc. covered Noile-Immune (This article was written by only Japanese, Sorry for your inconvenience); A newspaper article about the "<Osaka> Bio IR Day", company briefing sessions for individual investors, hosted by the Nihon Securities Journal Inc. held on Tuesday, December 10, covered Noile-Immune was published.

2024/12/16: (Correction) Partial Correction to “Notice of Re-prioritization of In-house Drug Discovery Pipelines and Change in Use of Funds Raised at the Time of Listing” (Japanese version already released on October 11)